MED-TEL_UK_LIMITED - Accounts


Company registration number 03446473 (England and Wales)
MED-TEL UK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021
PAGES FOR FILING WITH REGISTRAR
MED-TEL UK LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 6
MED-TEL UK LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2021
31 December 2021
- 1 -
2021
2020
Notes
£
£
£
£
Fixed assets
Investments
3
200,000
200,000
Current assets
Debtors
6
4,917,506
3,721,321
Cash at bank and in hand
4,719
6,939
4,922,225
3,728,260
Creditors: amounts falling due within one year
7
(4,237,862)
(3,106,762)
Net current assets
684,363
621,498
Net assets
884,363
821,498
Capital and reserves
Called up share capital
25,348
25,348
Share premium account
10,852,314
10,852,314
Other reserves
8,385,403
8,385,403
Profit and loss reserves
(18,378,702)
(18,441,567)
Total equity
884,363
821,498

The director of the company has elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 December 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 28 September 2022
Mr A  Tabbara
Director
Company Registration No. 03446473
MED-TEL UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2021
- 2 -
1
Accounting policies
Company information

Med-Tel UK Limited is a private company limited by shares incorporated in England and Wales. The registered office is 17 Harley Street, Marylebone, London, W1G 9QH.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

  • Section 3 'Financial Statement Presentation paragraph 3. l7(d)'.

  • Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

 

The financial statements of the company are consolidated in the financial statements of United Medical Enterprises Group LLP. These consolidated financial statements are available from Companies House.

The Cornpany is a parent Company that is also a subsidiary included in the consolidated financial statements of its ultimate parent undertaking established under the law of an EEA state and is therefore exempt from the requirement to prepare consolidated ffinancial statements undersection 400 of the Companies Act 2006.

1.2
Going concern

The directors have taken into consideration the underlying cashflows expected over a period of at least twelve months from the date of signing this report, together with available support offered by the Company's parent undertaking, and have determined that the company is able to continue as a going concern.true

1.3
Turnover

Turnover Turnover represents income earned via a subletting arrangement with a third party healthcare provider.

 

All income is exclusive of VAT and is recognised in the accounting period in which the services are rendered.

MED-TEL UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
1
Accounting policies
(Continued)
- 3 -
1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

MED-TEL UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
1
Accounting policies
(Continued)
- 4 -
1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.8
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Rentals paid under operating leases are charged to the Statement of Comprehensive Income on a straight line basis over the lease term.

 

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 

The Company has taken advantage of the optional exemption available on transition to FRS 102 which allows lease incentives on leases entered into before the date of transition to the standard 01 January 2018 to continue to be charged over the period to the first market rent review rather than the term of the lease.

 

Where assets leased to a third party give rights approximating to ownership (finance lease), the lessor recognises as a receivable an amount equal to the net investment in the lease i.e. the minimum lease payments receivable under the lease discounted at the interest rate implicit in the lease. This receivable is reduced as the lessee makes capital payments over the term of the lease.

 

A finance lease gives rise to two types of income: profit or loss equivalent to the profit or loss

resulting from outright sale of the asset being leased, at normal selling prices, reflecting any

applicable discounts, and finance income over the lease term.

 

Finance costs are charged to the Statement of Comprehensive Income over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2021
2020
Number
Number
Total
1
1
MED-TEL UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
2
Employees
(Continued)
- 5 -

The company holds the contracts of employment for staff who all work for a subsidiary company, Harley Street Medical Centre LLP. The substance is that the staff are employees of Harley Street Medical Centre LLP and therefore have been recognised as employees of the subsidiary, rather than Med-Tel UK Limited.

3
Fixed asset investments
2021
2020
£
£
Shares in group undertakings and participating interests
200,000
200,000
4
Subsidiaries

Details of the company's subsidiaries at 31 December 2021 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Harley Street Medical Centre LLP
17 Harley Street, Marylebone, London, W1G 9QH
Partner
50.00
5
Joint ventures

Details of the company's joint ventures at 31 December 2021 are as follows:

Name of undertaking
Registered office
Interest
% Held
held
Direct
Meriden Hospital Advanced Imaging Centre Limited
1st Floor, 30 Cannon Street, London, EC4M 6XH
Ordinary
50.00
6
Debtors
2021
2020
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
4,889,899
3,402,205
Other debtors
27,607
319,116
4,917,506
3,721,321
MED-TEL UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2021
- 6 -
7
Creditors: amounts falling due within one year
2021
2020
£
£
Trade creditors
93
213
Amounts owed to group undertakings
4,113,886
2,950,709
Taxation and social security
103,194
46,740
Accruals and deferred income
20,689
109,100
4,237,862
3,106,762

Howard De Walden Estates Limited hold a legal charge dated 2 November 2005 over all monies due or to become due from the company to chargee on any account whatsoever.

8
Reserves

Other reserves

 

Other reserves relate to a capital contribution reserve, which represents 1) The difference between the value of loan notes issued to the Company's parent and the restated value on the date of transition to FRS 102 and 2) The value of these loan notes which were written off by the lender during the prior year.

9
Parent company

The company's immediate parent is UME Diagnostics Limited. The smallest group in which the results of the company are consolidated is that headed by United Medical Enterprises Group LLP. Copies of United Medical Enterprises Group LLP financial statements are available from Companies House, Crown Way, Cardiff, CF14 3UZ.

 

The ultimate parent is United Medical Enterprises Group Limited (BC 343764), incorporated in the British Virgin Islands. This company is the largest group in which the results of the company are consolidated.

2021-12-312021-01-01false28 September 2022CCH SoftwareCCH Accounts Production 2022.100No description of principal activityMr A Tabbara034464732021-01-012021-12-31034464732021-12-31034464732020-12-3103446473core:CurrentFinancialInstrumentscore:WithinOneYear2021-12-3103446473core:CurrentFinancialInstrumentscore:WithinOneYear2020-12-3103446473core:CurrentFinancialInstruments2021-12-3103446473core:CurrentFinancialInstruments2020-12-3103446473core:ShareCapital2021-12-3103446473core:ShareCapital2020-12-3103446473core:SharePremium2021-12-3103446473core:SharePremium2020-12-3103446473core:OtherMiscellaneousReserve2021-12-3103446473core:OtherMiscellaneousReserve2020-12-3103446473core:RetainedEarningsAccumulatedLosses2021-12-3103446473core:RetainedEarningsAccumulatedLosses2020-12-3103446473bus:Director12021-01-012021-12-31034464732020-01-012020-12-3103446473core:Subsidiary12021-01-012021-12-3103446473core:Subsidiary112021-01-012021-12-3103446473core:JointVenture12021-01-012021-12-3103446473core:JointVenture112021-01-012021-12-3103446473bus:PrivateLimitedCompanyLtd2021-01-012021-12-3103446473bus:SmallCompaniesRegimeForAccounts2021-01-012021-12-3103446473bus:FRS1022021-01-012021-12-3103446473bus:AuditExemptWithAccountantsReport2021-01-012021-12-3103446473bus:FullAccounts2021-01-012021-12-31xbrli:purexbrli:sharesiso4217:GBP